Physician profile
Mark Eberbach
NPI 1750386744
$4,098.52
in general payments reported to CMS, 2019-2025
11 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,875 · 2020: $126 · 2021: $267 · 2022: $283 · 2023: $261 · 2024: $120 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,336.91 | 2019-2022 | |
| Abbvie INC. | $391.12 | 2023-2025 | |
| Sientra, INC. | $136.91 | 2021 | |
| Mentor Worldwide LLC | $64.65 | 2022-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Trevena, INC. | $45.01 | 2023 | Olinvyk |
| Merz North America, INC. | $33.87 | 2025 | |
| Mvp Orthopedics INC | $23.84 | 2022 | |
| Integra Lifesciences Corporation | $19.78 | 2023 | Durasorb Monofilament Mesh |
| Kowa Pharmaceuticals America, INC. | $17.05 | 2023 | Seglentis |
| Hikma Pharmaceuticals USA | $15.40 | 2022 | |
| Davol INC. | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Eberbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.